Sildenafil
Product Images NDC 50090-3082

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 50090-3082). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-7.jpg (Graph1)

A line graph depicting the percentage of subjects without a clinically worsening event over time from randomization (up to 112 days). Two curves are shown: a solid line for placebo and a dotted line for Sildenafil, with the Sildenafil group maintaining a higher percentage over time compared to placebo.*

FDA Label Image

Image-1.jpg (Image 1)

Chemical structure diagram of sildenafil, showing its molecular arrangement with various chemical groups including sulfonyl, methyl, and ethyl substituents, along with carboxylic acid moieties.*

FDA Label Image

Image-2.jpg (Image 2)

A line graph depicting change from baseline on the y-axis (in meters) over three time points labeled Week 4, Week 8, and Week 12. The graph compares effects of Sildenafil 40mg TID, Sildenafil 80mg TID, Sildenafil 20mg TID, and a placebo, with markers and vertical error bars indicating variability at each time point during the study.*

FDA Label Image

Image-3.jpg (Image 3)

A forest plot chart showing placebo-corrected changes in 6-minute walk distance (meters) for Sildenafil 20 mg administered three times daily. The chart compares subgroups by baseline walk distance, aetiology, pulmonary hypertension criteria, gender, age, mean pulmonary arterial pressure, and pulmonary vascular resistance index, with corresponding confidence intervals for each subgroup.*

FDA Label Image

Image-4.jpg (Image 4)

Kaplan-Meier plot showing estimated cumulative mortality rate over time in years for Sildenafil doses labeled High Dose, Medium Dose, and Low Dose. The plot depicts increasing mortality with higher doses over a period of 5 years, with number at risk indicated for each dose group at various time points.*

FDA Label Image

Image-5.jpg (Image 5)

A forest plot chart showing fold change and 90% confidence intervals for various interacting drugs affecting Sildenafil pharmacokinetics. It compares area under the curve (AUC) and maximum concentration (Cmax) relative to Sildenafil alone, with vertical solid line at x=1 for no change, and includes dose adjustment recommendations for each drug.*

FDA Label Image

Image-6.jpg (Image 6)

A chart showing fold change and 90% confidence intervals for various interacting drugs on pharmacokinetic parameters such as AUC and Cmax, relative to the interacting drug alone. The chart includes recommendations for dose adjustments, mostly indicating no dose adjustment, with a note that coadministration of ritonavir is not recommended. It features a horizontal axis labeled 'Change relative to interacting drug alone' with a vertical solid line at x=1 representing no change.*

FDA Label Image

Label Image (Lbl500903082)

Packaging label for Sildenafil 20 mg by A-S Medication Solutions. The label states the lot number, storage instructions to keep between 68 to 77 degrees Fahrenheit, and that each film coated tablet contains Sildenafil citrate equivalent to 20 mg of Sildenafil. The package contains 30 tablets. Label includes manufacturer and distributor information with a QR code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.